Article
No evidence of association of ENPP1 variants with type 2 diabetes or obesity in a study of 8,089 U.K. Caucasians.
Diabetes - 1 Nov 2006
Weedon Michael N, Shields Beverley, Hitman Graham, Walker Mark, McCarthy Mark I, Hattersley Andrew T, Frayling Timothy M
Abstract excerpt
Ectoenzyme nucleotide pyrophosphate phosphodiesterase 1 (ENPP1) is an inhibitor of insulin-induced activation of the insulin receptor. There is strong evidence from several previous studies that a common coding variant of ENPP1 (K121Q) and a three-marker haplotype (Q121, IVS20delT-11, and G+1044TGA) are associated with type 2 diabetes and obesity. We examined the impact of ENPP1 variation on type 2 diabetes and...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
